USPH

SEC source: 0001209191-22-029976 · doc4.xml · nonDerivative · entry 1

Motsenbocker Anne · CIK 0001904253 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,100

F1 · shares: The 1,600 shares of common stock were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 400 shares lapsed on each of July 1, 2022, October 1, 2022, January 1, 2023 and April 1, 2023, if she is a director of the Company on those dates.

F2 · balance_after: Includes the 1,600 shares of restricted stock granted under the Company equity plans mentioned in Note 1.

SEC source: 0001209191-22-029975 · doc4.xml · nonDerivative · entry 1

Trier Clayton · CIK 0001319561 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,580

F1 · shares: The 1,600 shares of common stock were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 400 shares lapsed on each of July 1, 2022, October 1, 2022, January 1, 2023 and April 1, 2023, if he is a director of the Company on those dates.

F2 · balance_after: Includes the 1,600 shares of restricted stock granted under the Company equity plans mentioned in Note 1.

SEC source: 0001209191-22-029943 · doc4.xml · nonDerivative · entry 1

KUNTZ EDWARD L · CIK 0001182168 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,680

F1 · shares: The 1,600 shares of common stock were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 400 shares lapsed on each of July 1, 2022, October 1, 2022, January 1, 2023 and April 1, 2023, if he is a director of the Company on those dates.

F2 · balance_after: Includes the 1,600 shares of restricted stock granted under the Company equity plans mentioned in Note 1.

SEC source: 0001209191-22-029942 · doc4.xml · nonDerivative · entry 1

Harris Bernard A Jr · CIK 0001337906 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,702

F1 · shares: The 1,600 shares of common stock were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 400 shares lapsed on each of July 1, 2022, October 1, 2022, January 1, 2023 and April 1, 2023, if he is a director of the Company on those dates.

F2 · balance_after: Includes the 1,600 shares of restricted stock granted under the Company equity plans mentioned in Note 1.

SEC source: 0001209191-22-029936 · doc4.xml · nonDerivative · entry 1

BROOKNER MARK J · CIK 0000938954 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,430

F1 · shares: The 1,600 shares of common stock were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 400 shares lapsed on each of July 1, 2022, October 1, 2022, January 1, 2023 and April 1, 2023, if he is a director of the Company on those dates.

F2 · balance_after: Includes the 1,600 shares of restricted stock granted under the Company equity plans mentioned in Note 1.

SEC source: 0001209191-22-029940 · doc4.xml · nonDerivative · entry 1

Chapman Harry S · CIK 0001500817 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,500

F1 · shares: The 1,600 shares of common stock were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 400 shares lapsed on each of July 1, 2022, October 1, 2022, January 1, 2023 and April 1, 2023, if he is a director of the Company on those dates.

F2 · balance_after: Includes the 1,600 shares of restricted stock granted under the Company equity plans mentioned in Note 1.

SEC source: 0001209191-22-019981 · doc4.xml · nonDerivative · entry 1

Chapman Harry S · CIK 0001500817 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,900

F1 · balance_after: Includes 370 shares of common stock which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as of April 1, 2022. If he is a director of the Company on that date.

SEC source: 0001209191-22-019422 · doc4.xml · nonDerivative · entry 4

Chapman Harry S · CIK 0001500817 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,180

F1 · balance_after: Includes 370 shares of common stock which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse on April 1, 2022, if he is a director of the Company on that date.

SEC source: 0001209191-22-019422 · doc4.xml · nonDerivative · entry 3

Chapman Harry S · CIK 0001500817 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,280

F1 · balance_after: Includes 370 shares of common stock which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse on April 1, 2022, if he is a director of the Company on that date.

SEC source: 0001209191-22-019422 · doc4.xml · nonDerivative · entry 2

Chapman Harry S · CIK 0001500817 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,280

F1 · balance_after: Includes 370 shares of common stock which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse on April 1, 2022, if he is a director of the Company on that date.

SEC source: 0001209191-22-019422 · doc4.xml · nonDerivative · entry 1

Chapman Harry S · CIK 0001500817 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,280

F1 · balance_after: Includes 370 shares of common stock which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse on April 1, 2022, if he is a director of the Company on that date.

SEC source: 0001209191-22-019101 · doc4.xml · nonDerivative · entry 1

Williams Eric Joseph · CIK 0001871391 · Co-Chief Operations Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,454

F1 · price: Includes the 8,898 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 590 shares on April 1, 2022 and thereafter on January 1, April 1, July 1 and October 1 of each year through April 1, 2025 with the final 1,228 shares restrictions lapsing as follows: 596 shares on July 1, 2025, 312 shares on October 1, 2025, and 320 shares on January 1, 2026.

SEC source: 0001209191-22-018695 · doc4.xml · nonDerivative · entry 1

Williams Eric Joseph · CIK 0001871391 · Co-Chief Operations Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,954

F1 · shares: The 5,000 shares of common stock were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse in 15 equal quarterly installments with the first 312 shares on April 1, 2022 and thereafter with 312 shares on April 1, July 1, October 1 and January 1 of each year with the final 320 shares lapsing on January 1, 2026, if he is employed by the Company on those dates.

F2 · balance_after: Includes the 5,000 shares in Footnote 1 and includes 3,898 shares which restrictions lapse as to 278 shares on April 1, 2022 and thereafter on January 1, April 1, July 1 and October 1 of each year with the final 284 shares restrictions lapsing on July 1, 2025.

SEC source: 0001209191-22-018694 · doc4.xml · nonDerivative · entry 1

REEVE GRAHAM D. · CIK 0001519948 · COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,305

F1 · shares: The 10,000 shares of common stock were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse in 15 equal quarterly installments with the first 624 shares on April 1, 2022 and thereafter with 624 shares on April 1, July 1, October 1 and January 1 of each year with the final 640 shares lapsing on January 1, 2026, if he is employed by the Company on those dates.

F2 · balance_after: Includes the 10,000 shares in Footnote 1 and includes 10,305 shares which restrictions lapse as to 1,433 on each of April 1, July 1 and October 1, 2022; 1,448 shares on January 1, 2023; 788 shares on each of April 1, July 1 and October 1, 2023; 794 shares on January 1, 2024; and 350 shares on each of April 1, July 1 and October 1, 2024 and January 1, 2025, if he is employed by the Company on those dates. Also includes 7,639 shares held in a trust in which Mr. Reeve is trustee and beneficiary.

SEC source: 0001209191-22-018693 · doc4.xml · nonDerivative · entry 1

READING CHRISTOPHER J · CIK 0001270356 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 89,638

F1 · shares: The 20,000 shares of common stock were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse in 16 equal quarterly installments with the first 1,250 shares on April 1, 2022 and with the final 1,250 shares lapsing on January 1, 2026, if he is employed by the Company on those dates.

F2 · balance_after: Includes the 20,000 shares in Footnote 1 and includes 20,711 shares which restrictions lapse as to 2,876 on each of April 1, July 1 and October 1, 2022; 2,879 shares on January 1, 2023; 1,598 shares on each of April 1, July 1 and October 1, 2023; 1,610 shares on January 1, 2024; and 700 shares on each of April 1, July 1 and October 1, 2023 and January 1, 2025, if he is employed by the Company on those dates.

SEC source: 0001209191-22-018691 · doc4.xml · nonDerivative · entry 1

HENDRICKSON CAREY P · CIK 0001482760 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,188

F1 · shares: The 7,500 shares of common stock were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse in 15 equal quarterly installments with the first 468 shares on April 1, 2022 and thereafter with 468 shares on April 1, July 1, October 1 and January 1 of each year with the final 480 shares lapsing on January 1, 2026, if he is employed by the Company on those dates.

F2 · balance_after: Includes the 7,500 shares in Footnote 1 and includes 2,538 shares which restrictions lapse as to 230 shares on April 1, 2022 and thereafter on January 1, April 1, July 1 and October 1 of each year with the final 238 shares restrictions lapse on October 1, 2024.

SEC source: 0001209191-22-014493 · doc4.xml · nonDerivative · entry 1

REEVE GRAHAM D. · CIK 0001519948 · COO

10b5-1 filing: Not disclosed

Ownership: Indirect · Reeve Trust

Disclosed balance after: 7,639

F1 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $89.68 - $91.11, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

SEC source: 0001209191-22-003746 · doc4.xml · nonDerivative · entry 1

Motsenbocker Anne · CIK 0001904253 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 500

F1 · shares: The 500 shares of common stock were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse for the 500 shares on April 1, 2022.

F2 · balance_after: Includes the 500 shares of common stock that were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan detailed in Footnote 1.

SEC source: 0001209191-21-070494 · doc4.xml · nonDerivative · entry 1

READING CHRISTOPHER J · CIK 0001270356 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,638

F1 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $93.75 - $94.00, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

F2 · balance_after: Includes 24,852 shares which restrictions lapse as to 4,141 on January 1, 2022; 2,876 on each of April 1, July 1 and October 1, 2022; 2,879 shares on January 1, 2023; 1,598 shares on each of April 1, July 1 and October 1, 2023; 1,610 shares on January 1, 2024; and 700 shares on each of April 1, July 1 and October 1, 2023 and January 1, 2025, if he is employed by the Company on those dates.

SEC source: 0001209191-21-068262 · doc4.xml · nonDerivative · entry 2

REEVE GRAHAM D. · CIK 0001519948 · COO

10b5-1 filing: Not disclosed

Ownership: Indirect · Reeve trust

Disclosed balance after: 7,845

F2 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $94.00 to $94.42 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc. any of its shareholders or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

SEC source: 0001209191-21-068491 · doc4.xml · nonDerivative · entry 1

Gilmartin Kathleen A · CIK 0001741732 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,680

F1 · price: The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $94.08 to $94.29, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

F2 · balance_after: Includes 740 shares of common stock which was granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 370 shares lapsed on each of January 1, 2022 and April 1, 2022, if she is a director of the Company on those dates.

SEC source: 0001209191-21-054050 · doc4.xml · nonDerivative · entry 1

McDowell Glenn · CIK 0001315304 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,867

F1 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $116.40 to $117.85, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

SEC source: 0001209191-21-053783 · doc4.xml · nonDerivative · entry 2

Chapman Harry S · CIK 0001500817 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,500

F1 · balance_after: Includes 1,110 shares of common stock which was granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 370 shares lapsed on each of October 1, 2021, January 1, 2022 and April 1, 2022, if he is a director of the Company on those dates.

SEC source: 0001209191-21-053783 · doc4.xml · nonDerivative · entry 1

Chapman Harry S · CIK 0001500817 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,500

F1 · balance_after: Includes 1,110 shares of common stock which was granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 370 shares lapsed on each of October 1, 2021, January 1, 2022 and April 1, 2022, if he is a director of the Company on those dates.

SEC source: 0001209191-21-052422 · doc4.xml · nonDerivative · entry 1

Williams Eric Joseph · CIK 0001871391 · Co-Chief Operations Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,954

F1 · shares: The 4,454 shares of common stock were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse in 15 equal quarterly installments with the first 278 shares on October 1, 2021 and thereafter with 278 shares on January 1, April 1 and October 1 of each year with the final 284 shares lapsing on July 1, 2025, if he is employed by the Company on those dates.

F2 · balance_after: Includes the 4,454 shares of common stock that was granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan detailed in Footnote 1.

SEC source: 0001209191-21-050817 · doc4.xml · nonDerivative · entry 1

HENDRICKSON CAREY P · CIK 0001482760 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,688

F1 · price: The price reported is a weighted average price ($112.85). The shares were purchased in multiple transactions at prices ranging from $112.53 to $113.00 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.

F2 · balance_after: Includes 2,998 shares which restrictions lapse as to 230 shares on October 1, 2021 and thereafter on January 1, April 1, July 1 and October 1 of each with the final 238 shares restrictions lapse on October 1, 2024.

SEC source: 0001209191-21-050678 · doc4.xml · nonDerivative · entry 2

REEVE GRAHAM D. · CIK 0001519948 · COO

10b5-1 filing: Not disclosed

Ownership: Indirect · Reeve Trust

Disclosed balance after: 6,936

F2 · price: The price reported is a weighted average price ($114.15). The shares were sold in multiple transactions at prices ranging from $113.96 to $114.42 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

SEC source: 0001209191-21-050594 · doc4.xml · nonDerivative · entry 4

Chapman Harry S · CIK 0001500817 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,500

F1 · shares: Disgorgement has occurred, and was completed immediately upon knowledge that such disgorgement was necessary

F2 · balance_after: Includes 1,110 shares of common stock which was granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 370 shares lapsed on each of October 1, 2021, January 1, 2022 and April 1, 2022, if he is a director of the Company on those dates.

SEC source: 0001209191-21-050594 · doc4.xml · nonDerivative · entry 3

Chapman Harry S · CIK 0001500817 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,980

F1 · shares: Disgorgement has occurred, and was completed immediately upon knowledge that such disgorgement was necessary

F2 · balance_after: Includes 1,110 shares of common stock which was granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 370 shares lapsed on each of October 1, 2021, January 1, 2022 and April 1, 2022, if he is a director of the Company on those dates.

SEC source: 0001209191-21-050594 · doc4.xml · nonDerivative · entry 2

Chapman Harry S · CIK 0001500817 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,500

F1 · shares: Disgorgement has occurred, and was completed immediately upon knowledge that such disgorgement was necessary

F2 · balance_after: Includes 1,110 shares of common stock which was granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 370 shares lapsed on each of October 1, 2021, January 1, 2022 and April 1, 2022, if he is a director of the Company on those dates.

SEC source: 0001209191-21-050594 · doc4.xml · nonDerivative · entry 1

Chapman Harry S · CIK 0001500817 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,980

F1 · shares: Disgorgement has occurred, and was completed immediately upon knowledge that such disgorgement was necessary

F2 · balance_after: Includes 1,110 shares of common stock which was granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 370 shares lapsed on each of October 1, 2021, January 1, 2022 and April 1, 2022, if he is a director of the Company on those dates.

SEC source: 0001209191-21-038140 · doc4.xml · nonDerivative · entry 3

Trier Clayton · CIK 0001319561 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,980

F2 · balance_after: Includes 1,480 shares of common stock which was granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 370 shares on each of July 1, 2021, October 1, 2021, January 1, 2022 and April 1, 2022, if he is a director of the Company on those dates.

SEC source: 0001209191-21-038140 · doc4.xml · nonDerivative · entry 2

Trier Clayton · CIK 0001319561 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,034

F2 · balance_after: Includes 1,480 shares of common stock which was granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 370 shares on each of July 1, 2021, October 1, 2021, January 1, 2022 and April 1, 2022, if he is a director of the Company on those dates.

SEC source: 0001209191-21-037600 · doc4.xml · nonDerivative · entry 1

BROOKNER MARK J · CIK 0000938954 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,830

F1 · balance_after: Includes 1,480 shares of common stock which was granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 370 shares lapsed on each of July 1, 2021, October 1, 2021, January 1, 2022 and April 1, 2022, if he is a director of the Company on those dates.

SEC source: 0001209191-21-038140 · doc4.xml · nonDerivative · entry 1

Trier Clayton · CIK 0001319561 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,061

F1 · price: The price reported is a weighted average price ($119.92). The shares were sold in multiple transactions at prices ranging from $119.91 to $119.99 per share, inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.

F2 · balance_after: Includes 1,480 shares of common stock which was granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 370 shares on each of July 1, 2021, October 1, 2021, January 1, 2022 and April 1, 2022, if he is a director of the Company on those dates.

SEC source: 0001209191-21-036309 · doc4.xml · nonDerivative · entry 1

Trier Clayton · CIK 0001319561 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,480

F1 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $120.21 to $120.39 per share. The reporting person undertakes to provide to U.S. Physical Therapy, Inc. any of its shareholders or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

F2 · balance_after: Includes 1,480 shares of common stock which was granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 370 shares lapsed on each of July 1, 2021, October 1, 2021, January 1, 2022 and April 1, 2022, if he is a director of the Company on those dates.

SEC source: 0001209191-21-036189 · doc4.xml · nonDerivative · entry 1

BROOKNER MARK J · CIK 0000938954 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,600

F1 · balance_after: Includes 1,480 shares of common stock which was granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 370 shares lapsed on each of July 1, 2021, October 1, 2021, January 1, 2022 and April 1, 2022, if he is a director of the Company on those dates.

SEC source: 0001209191-21-034778 · doc4.xml · nonDerivative · entry 1

Gilmartin Kathleen A · CIK 0001741732 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,680

F1 · price: The price reported is a weighted average price ($116.67). The shares were purchased in multiple transactions at prices ranging from $116.44 to, and including, $116.93 per share. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.

F2 · balance_after: Includes 1,480 shares of common stock which was granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 370 shares lapsed on each of July 1, 2021, October 1, 2021, January 1, 2022 and April 1, 2022, if she is a director of the Company on those dates.

SEC source: 0001209191-21-033898 · doc4.xml · nonDerivative · entry 1

BROOKNER MARK J · CIK 0000938954 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,080

F1 · shares: The 1,480 shares of common stock was granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 370 shares lapsed on each of July 1, 2021, October 1, 2021, January 1, 2022 and April 1, 2022, if he is a director of the Company on those dates.

F2 · balance_after: Includes the 1,480 shares of restricted stock granted under the Company equity plans mentioned in Note 1.

SEC source: 0001209191-21-033897 · doc4.xml · nonDerivative · entry 1

Trier Clayton · CIK 0001319561 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,680

F1 · shares: The 1,480 shares of common stock was granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 370 shares lapsed on each of July 1, 2021, October 1, 2021, January 1, 2022 and April 1, 2022, if he is a director of the Company on those dates.

F2 · balance_after: Includes the 1,480 shares of restricted stock granted under the Company equity plans mentioned in Note 1.

SEC source: 0001209191-21-033894 · doc4.xml · nonDerivative · entry 1

Swanson Regg E. · CIK 0001412473 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,680

F1 · shares: The 1,480 shares of common stock was granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 370 shares lapsed on each of July 1, 2021, October 1, 2021, January 1, 2022 and April 1, 2022, if he is a director of the Company on those dates.

F2 · balance_after: Includes the 1,480 shares of restricted stock granted under the Company equity plans mentioned in Note 1.

SEC source: 0001209191-21-033892 · doc4.xml · nonDerivative · entry 1

KUNTZ EDWARD L · CIK 0001182168 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,080

F1 · shares: The 1,480 shares of common stock was granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 370 shares lapsed on each of July 1, 2021, October 1, 2021, January 1, 2022 and April 1, 2022, if he is a director of the Company on those dates.

F2 · balance_after: Includes the 1,480 shares of restricted stock granted under the Company equity plans mentioned in Note 1.

SEC source: 0001209191-21-033891 · doc4.xml · nonDerivative · entry 1

Harris Bernard A Jr · CIK 0001337906 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,102

F1 · shares: The 1,480 shares of common stock was granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 370 shares lapsed on each of July 1, 2021, October 1, 2021, January 1, 2022 and April 1, 2022, if he is a director of the Company on those dates.

F2 · balance_after: Includes the 1,480 shares of restricted stock granted under the Company equity plans mentioned in Note 1.

SEC source: 0001209191-21-033889 · doc4.xml · nonDerivative · entry 1

Gilmartin Kathleen A · CIK 0001741732 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,680

F1 · shares: The 1,480 shares of common stock was granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 370 shares lapsed on each of July 1, 2021, October 1, 2021, January 1, 2022 and April 1, 2022, if she is a director of the Company on those dates.

F2 · balance_after: Includes the 1,480 shares of restricted stock granted under the Company equity plans mentioned in Note 1.

SEC source: 0001209191-21-033888 · doc4.xml · nonDerivative · entry 1

Chapman Harry S · CIK 0001500817 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,480

F1 · shares: The 1,480 shares of common stock was granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 370 shares lapsed on each of July 1, 2021, October 1, 2021, January 1, 2022 and April 1, 2022, if he is a director of the Company on those dates.

F2 · balance_after: Includes the 1,480 shares of restricted stock granted under the Company equity plans mentioned in Note 1.

SEC source: 0001209191-21-031985 · doc4.xml · nonDerivative · entry 1

BROOKNER MARK J · CIK 0000938954 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,600

SEC source: 0001209191-21-031177 · doc4.xml · nonDerivative · entry 2

REEVE GRAHAM D. · CIK 0001519948 · COO

10b5-1 filing: Not disclosed

Ownership: Indirect · Reeve Trust

Disclosed balance after: 6,586

F2 · price: The price reported is a weighted average price ($117.99). The shares were sold in multiple transactions at prices ranging from $117.97 to $118.20 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

SEC source: 0001209191-21-023151 · doc4.xml · nonDerivative · entry 8

Chapman Harry S · CIK 0001500817 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,000

F2 · shares: This purchase transaction was inadvertent and the required disgorgement already has occurred.

F1 · balance_after: Includes 400 shares of common stock which was granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions will lapse on the 400 shares on April 1, 2021, if he is a director of the Company on that date.

SEC source: 0001209191-21-023151 · doc4.xml · nonDerivative · entry 7

Chapman Harry S · CIK 0001500817 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,000

F1 · balance_after: Includes 400 shares of common stock which was granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions will lapse on the 400 shares on April 1, 2021, if he is a director of the Company on that date.

SEC source: 0001209191-21-023151 · doc4.xml · nonDerivative · entry 6

Chapman Harry S · CIK 0001500817 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,000

F1 · balance_after: Includes 400 shares of common stock which was granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions will lapse on the 400 shares on April 1, 2021, if he is a director of the Company on that date.